A laboratory study has shown the multi-strain liquid probiotic Symprove to be effective in inhibiting the growth of harmful bacteria associated with diarrhoea.
Bacterial pathogens are a leading cause of infectious diarrhoea and can be challenging to manage clinically, particularly with concerns around antimicrobial resistance from antibiotic use.
Probiotics have garnered attention as a promising non-antibiotic intervention for maintaining gut health and combating gut infections, particularly as they have a strong safety profile and are very unlikely to drive antimicrobial resistance.
Published in BMC Microbiology, the study was conducted independently by microbiologists at the University of Ghana. The aim was to evaluate the potential of Symprove in inhibiting diarrheal pathogens, specifically Vibrio cholerae (which causes cholera), Escherichia coli, Listeria monocytogenes and Staphylococcus aureus (associated with food poisoning).
Using their laboratory model, researchers demonstrated that Symprove “exhibits significant inhibitory effects against key diarrheal pathogens such as V. cholerae, E. coli, S. aureus, and L. monocytogenes”. These findings are also consistent with other laboratory studies exploring the effect of Symprove against gut pathogens, including E. Coli, Clostridium Difficile, MRSA and Shigella species.
The authors conclude that Symprove has the potential to support the management of gut infections caused by these pathogens, but more research is needed.
The full published paper is available in BMC Microbiology (Dodoo CC, et al. BMC Microbiology. 2025;26(1):20).
About Symprove:
Symprove is the UK's No.1 live and active bacteria supplement*.
Founded in 1986 by Barry Smith, it was created to deliver good bacteria to the gut alive and active. Unlike many powder and capsule probiotics, Symprove's unique water-based formulation is designed to keep its four strains of live bacteria alive so they reach the gut ready to work**.
The brand continues to invest in scientific research, with studies carried out at leading institutions including King's College Hospital, Sheffield Hallam and University College London.
For samples or more information, please get in touch with press@symprove.com.
* UK's No.1 live and active bacteria supplement. Source Euromonitor International Ltd; Consumer Health 2026ed., Symprove retail value sales, UK 2025 data.
**Symprove’s friendly bacteria are proven to reach your gut alive and active based on a validated, in-vitro model (Simulator of the Human Intestinal Microbial Ecosystem; SHIME®) showing 99.3% of bacteria remain viable in gut simulator conditions (Moens et al 2019).